Dual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunction
Options
BORIS DOI
Date of Publication
March 17, 2020
Publication Type
Article
Division/Institute
Subject(s)
Series
Annals of Hematology & Oncology
ISSN or ISBN (if monograph)
2375-7965
Publisher
Austin Publishing Group
Language
English
Description
We here report an informative case of severe bleeding diathesis in a patient with Chronic Lymphocytic Leukaemia (CLL), due to Acquired Von Willebrand Syndrome (AVWS) and impaired platelets aggregation under the treatment with Ibrutinib.
Keywords: CLL; Acquired von Willebrand syndrome; Ibrutinib; Bleeding
Keywords: CLL; Acquired von Willebrand syndrome; Ibrutinib; Bleeding
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| hematology-v7-id1290.pdf | Adobe PDF | 3.51 MB | published |